This section focuses on an overview of active pharmaceutical ingredients as well as their manufacturing processes and uses. Also, please check out the introduction to active pharmaceutical ingredients (API) manufacturers, supply chain issues, active pharmaceutical ingredients suppliers, and price trends. Sinofi’s technical sales can help our customers buy the FDA and GMP-certified APIs in bulk for their industry applications at wholesale prices based on CAS numbers.
Table of Contents
What are Active Pharmaceutical Ingredients (API)?
Active pharmaceutical ingredients (API) are the essential components of any drug that produce its effects. Some medications, such as combination therapies, have multiple active ingredients to treat different diseases and alleviate symptoms. They are created using highly technological industrial processes, both during the R&D and the commercial production phase. The United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the National Medical Products Administration (NMPA) have developed and set voluntary standards for active pharmaceutical ingredients (APIs) used in drug production.
Bulk Active Pharmaceutical Ingredients API Manufacturers
Large API manufacturers are focusing on various strategic initiatives for manufacturing and developing APIs, which are expected to contribute to the market’s growth. This market segment is dominated by major players like Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals Inc., Aurobindo, AbbVie Inc., AstraZeneca, BASF, Bayer AG, Apex Healthcare Ltd, Dr. Reddy’s Laboratories, Lupin, Viatris (Mylan), Merck & Co. Inc., and others. However, the API manufacturing industry is currently highly fragmented, with several companies that produce APIs for innovative medicines and generics. API manufacturers in China and India began offering superior-quality APIs and other intermediates for regulated markets. Sinofi is a bulk active pharmaceutical ingredients manufacturer and supplier in China, and we have a manufacturing facility that produces APIs and chemicals in 2,500 square meters. Our factory is located in the Anqing National High-tech Industrial Development Zone in Anhui Province. We manufacture and supply different FDA- and GMP-certified active pharmaceutical ingredients at bulk prices for our clients around the world.
Manufacturing Process of Active Pharmaceutical Ingredients
The manufacturing processes of active pharmaceutical ingredients include chemical synthesis and biotechnology. Synthetic active pharmaceutical ingredients are manufactured using many process steps that need to be coordinated. On the one hand, there is the need to use production lines flexibly; on the other hand, cross-contamination of the different APIs must be avoided. It is increasingly important to utilize the capacities of production plants worldwide as efficiently as possible. The key to meeting these challenges lies in the optimization of the processes. Biotech API is driving the API market with increased applications, technological advancements, and the advantages of biologics and biosimilars. Biologics are produced from living organisms or contain components of living organisms. They include recombinant proteins, tissues, genes, allergens, cells, blood components, and vaccines. Biosimilars are biotherapeutic products similar in quality, safety, and efficacy to biological drugs. Some technological advancements of biotech high potency active pharmaceutical ingredients (HPAPI) manufacturing are single-use bioreactors, as these systems are composed of plastic material, which has been sealed and sterilized with gamma radiation. Single-use bioreactors have become a significant tool in manufacturing biotech API and API. It is beneficial for downstream and upstream processes.
Bulk Active Pharmaceutical Ingredient Suppliers
Active pharmaceutical ingredient suppliers play a crucial role in ensuring that pharmaceutical manufacturers have a stable availability of high-quality API ingredients for their production. Sinofi is a bulk active pharmaceutical ingredients supplier in China, and we have a warehouse with 1,200 square meters for active pharmaceutical ingredients and chemicals. Currently, we ship our APIs from China due to cost considerations. In the future, we plan to establish distribution hubs in the EU and USA to shorten the shipping time of our FDA and GMP-certified active pharmaceutical ingredients.
Supply Chain of Active Pharmaceutical Ingredients
Pharmaceutical companies benefit from outsourcing API production, as it eradicates the need for installing expensive manufacturing units and labor forces. Hence, the need for cost savings boosts the outsourcing of API production. Strategic outsourcing by companies allows them to focus on core competencies, which results in increased productivity. However, this trend has taken a different turn during the COVID-19 pandemic. According to the Medicines and Healthcare Products Regulatory Agency (MHRA), about 40% of the total APIs manufactured worldwide are contributed by Chinese manufacturers. Pharmaceutical manufacturers are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer. They are planning to diversify their API supply chain to various countries.
Wholesale and buy Active Pharmaceutical Ingredients
As a leading active pharmaceutical ingredients manufacturer, we not only supply bulk ingredients to large pharmaceutical manufacturers. We also wholesale our API ingredients and chemicals to small customers and pet lovers. Because they need a wide variety of active pharmaceutical ingredients and chemicals in small quantities. To serve them, we can wholesale our API ingredients at wholesale prices and provide a one-stop purchasing and shipping service according to our customers’ needs.
Price Trends of Active Pharmaceutical Ingredients
Prices of active pharmaceutical ingredients vary globally and depend on various factors, such as where they are being manufactured and supplied. The production costs incurred by the manufacturers play a crucial role in pricing active pharmaceutical ingredients. For instance, the availability of cheaper raw materials for API production in China and India allows manufacturers from these regions to supply products at low costs. Furthermore, the purity and grade of APIs play an essential role in their pricing. Factors such as incoterms, insurance, freight charges, and export duties can further increase the shipment prices, thereby increasing the API’s per gram/per kg prices. Government taxes can also adversely influence API prices; sometimes, they can exceed as much as 100% of production costs.
The COVID-19 pandemic has led to the disruption of global API supply chains. However, most production facilities had re-established functioning by October 2020, but active pharmaceutical ingredients manufacturers have increased the prices of API owing to COVID-19. During the pandemic, most APIs were shipped via cargo flights, increasing APIs’ prices. There is a high degree of redundancy due to a vast number of companies, and these companies have very limited differences between their technology platforms and manufacturing capabilities. Thus, competition between substitute therapies and the patents is likely to push the API prices down over time.
Active Pharmaceutical Ingredient uses
Active pharmaceutical ingredients are mainly used to treat cardiology, pulmonology, oncology, ophthalmology, neurology, orthopedics, and other diseases. There are numerous applications for the APIs to treat diseases and disorders. These active pharmaceutical ingredients include small molecules and large molecules like peptides, monoclonal antibodies, and others.
In conclusion, Various API companies manufacture and supply active pharmaceutical ingredients to different countries worldwide. However, they must deal with various challenges, such as growing competition from low-cost countries and overcapacity.